Publications
-
NF-kappa B signalling-related signatures are connected with mesenchymal phenotype of circulating tumour cells in non-metastatic breast cancer
Cancers (Basel) 2019, 11(12):1961 (doi: 10.3390/cancers11121961)
Go to publication
-
Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium
Oncotarget 2017, 8:106415-106428 (doi: 10.18632/oncotarget.22468)
Go to publication
-
Potential role of Jagged 1 in metastatic progression of human breast carcinomas
Clinical Chemistry 2016, 62(2):378-86 (doi: 10.1373/clinchem.2015.246686)
Go to publication
-
Circulating tumor cells in patients with testicular germ cell tumors
Clinical Cancer Research 2014, 20(14): 3830-3841 (doi: 10.1158/1078-0432.CCR-13-2819)
Go to publication
-
Plasticity of disseminating cancer cells in patients with epithelial malignancies
Cancer & Metastasis Reviews 2012, 31(3-4): 673-687 (doi: 10.1007/s10555-012-9370-z)
Go to publication
-
Clinical relevance and biology of circulating tumor cells
Breast Cancer Research 2011, 13(6): 228 (doi: 10.1186/bcr2940)
Go to publication
-
BRCA1 loss pre-existing in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood
Clinical Cancer Research 2010, 16: 3340-3348 (doi: 10.1158/1078-0432.CCR-10-0150)
Go to publication